Blueprint Medicines Corp

Ownership Transactions Reported by 23 Insiders

Symbol
BPMC on Nasdaq
Location
45 Sidney Street, Cambridge, Massachusetts

Insiders trading volume in the past year

Blueprint Medicines Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kate Haviland Chief Executive Officer $13.9M -$1.13M -7.52% Mar 7, 2024
Jeffrey W. Albers Director $13.4M -$10.5M -44% Sep 9, 2024
Christina Rossi Chief Operating Officer $8.22M -$550K -6.28% Jul 1, 2024
Alexis Borisy Director $7.8M Jun 12, 2024
Fouad Namouni President, R & D $6.59M -$578K -8.06% Mar 7, 2024
Michael Landsittel Chief Financial Officer $6.4M -$4.02M -38.6% Aug 15, 2024
Nicholas Lydon Director $6.1M Jun 12, 2024
Percy H. Carter Chief Scientific Officer $5.49M -$887K -13.9% Jul 1, 2024
Tracey L. McCain Evp And Chief Legal Officer $5.49M -$471K -7.91% Mar 7, 2024
Debra Durso-Bumpus Chief People Officer $4.87M -$9.62M -66.4% Jul 3, 2024
Philina Lee Chief Commercial Officer $3.24M -$4.9M -60.2% Aug 5, 2024
L. Becker Hewes Chief Medical Officer $3.1M -$4.67M -60.1% Jun 4, 2024
Christopher K. Murray Chief Technical Operations $3.07M -$1.24M -28.7% Mar 7, 2024
Mark Alan Goldberg Director $1.92M Jun 12, 2024
Ariel Hurley Principal Accounting Officer $1.59M -$1.74M -52.3% May 15, 2024
Lonnel Coats Director $1.39M Jun 12, 2024
Lynn Seely Director $1.39M Jun 12, 2024
Daniella Beckman Director $1.14M Jun 12, 2024
Habib J. Dable Director $919K Jun 12, 2024
John Tsai Director $919K Jun 12, 2024
George Demetri Director $757K Jun 21, 2022
Charles A. Rowland Jr Director $523K Jun 2, 2021
Tango Therapeutics, Inc. Director $306K Dec 8, 2021

Recent Insider Transactions by Companies or Individuals for Blueprint Medicines Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.